Ballentine Partners’s Arcosa ACA Stock Holding History

Ballentine Partners’s Portfolio ACA Stock Details ACA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$380K	Buy	2,602 +850	+49%	+$124K	﹤0.01%	716
2026 Q2	$255K	Buy	+1,752	New	+$218K	﹤0.01%	884

Other funds holding ACA

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Neuberger Berman Group New York $148B AUM 31.56% 1-Year Est. Return

Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $10.2B AUM 0.67% 1-Year Est. Return

Soros Fund Management New York $8.51B AUM 25.51% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Ballentine Partners's ACA Position: Q3 2026 in Review

Ballentine Partners increased its Arcosa (ACA) stake by 49% in Q3 2026, buying an estimated $124K and bringing the position to 2,602 shares worth $380K. The position accounts for ﹤0.01% of the portfolio, ranked #716.

Ballentine Partners first reported a position in ACA in Q2 2026 and has held it in 2 quarters since. 334 funds tracked by Wall St. Rank hold ACA as of Q3 2026.

Ballentine Partners held 2,602 shares of Arcosa worth $380K as of Q3 2026.
Ballentine Partners bought 850 Arcosa shares in Q3 2026, an estimated $124K.
Arcosa made up ﹤0.01% of Ballentine Partners's portfolio in Q3 2026, its #716 holding.
Ballentine Partners first reported a position in Arcosa in Q2 2026 and has held it in 2 quarters since.
334 funds tracked by Wall St. Rank held Arcosa as of Q3 2026.

Based on Ballentine Partners's 13F filing for Q3 2026, filed 13 Nov 2026.